ASNC Society

What is your interpretation of the findings? Vote now. Case will post next week on ASNC.org.

#CVNuc #ThinkPET case poll: 55-yr-old man with BMI 38, risk factors, and calcium score of 995 undergoes PET MPI for dyspnea. What is your interpretation of the findings? Vote below.

Great opportunity to be mentored by leaders in nuclear cardiology and cardiovascular imaging!

Great opportunity to come join us in Las Vegas this fall!

🚨 Deadline approaching! Apply to ASNC’s Leadership Development Programs by Monday, April 6. 💥 Advance your career with expert mentorship, hands-on training, ongoing networking opportunities, & deepen your engagement with the ASNC community. Apply now👉bit.ly/4t9Npv0

In a study of 8,357 patients, an automated machine learning model that integrated clinical and PET MPI data discriminated risk more accurately than logistic regression or a deep neural network. @fares_alahdab @mumedicine @drAhmedIA @YaleMed @almallahmo @MethodistHosp @DeBakeyCVedu Read now👉bit.ly/4rTyJiC

Hemoglobin concentration affects resting MBF but not stress MBF in ¹⁵O-water PET MPI, indicating stress MBF may serve as a more robust and reliable measure of maximal coronary flow capacity than MFR, particularly in patients with anemia. Read now👉bit.ly/4m1XVCt

📢All physicians, scientists, & technologists are invited to submit their science for consideration to be presented at #ASNC2026. Submit your abstract and/or case by Friday, April 10! Learn more👉bit.ly/4scUHNV

ASNC leadership development program will give you the opportunity to accelerate your professional growth! Don’t miss this opportunity! @MyASNC #CVNuc

🚀 Exciting discussions at the #ASNC / @MyASNC Fellows‑in‑Training Nuclear Cardiology ShowCase today! From advanced PET stress testing to quantifying myocardial blood flow, FIT are highlighting how imaging drives precision in ischemia evaluation. Exceptional work by Drs. Friederike Keating, Saurabh Malhotra, and all presenters!

🙌🏻‼️ Important takeaways from my @MyASNC presentation.

Great case presentation by our research fellow @MariaAlwan_ 👏 Rb-82 PET showed normal perfusion, but F-18 flurpiridaz PET unmasked LAD territory ischemia ; highlighting the superior resolution and diagnostic sensitivity of F-18 imaging. @MyASNC

📢 Applications for ASNC's Leadership Development Programs are due on April 6! 💼 Take the next step in your career with mentorship, skill-building, and networking opportunities that foster career advancement and a deeper connection with ASNC. Apply👉bit.ly/4t9Npv0

🚨 LAST CALL: Early Registration for #ICNC2026 ends TOMORROW (March 25)! Don’t miss your chance to save up to €200! Join global experts for: 🔬 38 scientific sessions 🎓 Up to 11 CME credits 🎯 Focused tracks: AI & Technology, Amyloid & Other Cardiomyopathies, Infection & Inflammation, Ischemic Heart Disease + more ⏳ Secure your spot now: bit.ly/4qJqzJj

Early registration deadline approaching! 🚨 Secure your spot at #ICNC2026, co-organised by #EANM and @MyASNC, and save up to €200 with our early registration rate. ⏰ Early registration deadline: March 25, 2026 🔗 Register now: icnc.community/registration/

🎙️ Major debates are coming to #ICNC2026. Experts will go head-to-head on key questions in cardiovascular imaging—from FDG-PET in infective endocarditis to PET vs MR in cardiomyopathy imaging and CT vs nuclear cardiology in the future of CAD diagnosis. 📍 Berlin | May 17–19 Be in the room when the experts debate! 👉bit.ly/4qJqzJj @EANM_NucMed

Advance your lab with the latest in nuclear cardiology at #ICNC2026 !🫀 Join global experts May 17–19 in Berlin for 38 sessions covering SPECT, cardiac PET, AI, novel radiotracers, MBF quantification, & more. Learn, connect, & explore at #ICNC2026! Register🔗bit.ly/4qJqzJj

🧬🫀 Join us Mar 13–15, 2026 for the ASNC Masterclass in Cardiac Amyloidosis!💥 Free registration! Pleased to serve as social media moderator!! @MyASNC @DrCAkincioglu @kleechuyMD @ADispenzieri @MathewMaurer @frederickruberg @SinghVasvi #Amyloidosis #CardioTwitter

📢 Starting This Friday—Complimentary Masterclass in Cardiac Amyloidosis! Join us March 13–15 for an in-depth virtual program designed to help today’s practitioners stay current in the rapidly evolving field of cardiac amyloidosis. Register now👉bit.ly/4aYE8zH